Remdesivir is active in vitro against tick-borne encephalitis virus and selects for resistance mutations in the viral RNA-dependent RNA polymerase. - Nyström K; Trybala E; Said J; Roth A; Patzi Churqui M; Kärmander A; Cihlar T; Bilello JP; Bergström T; Lagging M (Infectious diseases (London, England), 2025)